1. Alessandria C., Ozdogan O., Guevara M., Restuccia T., Jimenez W., Arroyo V., Rodes J., Gines P.. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation.
Hepatology 41:2005;1282–1289.
2. D'Amico G., Garcia-Tsao G., Pagliaro L.. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.
J Hepatol 44:2006;217–231.
3. Schepke M., Appenrodt B., Heller J., Zielinski J., Sauerbruch T.. Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study.
Liver Int 26:2006;834–839.
4. Garcia-Tsao G., Parikh C.R., Viola A.. Acute kidney injury in cirrhosis.
Hepatology 48:2008;2064–2077.
5. Wu C.C., Yeung L.K., Tsai W.S., Tseng C.F., Chu P., Huang T.Y., Lin Y.F., Lu K.C.. Incidence and factors predictive of acute renal failure in patients with advanced liver cirrhosis.
Clin Nephrol 65:2006;28–33.
6. Barrett B.J., Parfrey P.S.. Prevention of nephrotoxicity induced by radiocontrast agents.
N Engl J Med 331:1994;1449–1450.
7. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D.. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.
Ann Intern Med 130:1999;461–470.
8. Kim S.M., Cha R.H., Lee J.P., Kim D.K., Oh K.H., Joo K.W., Lim C.S., Kim S., Kim Y.S.. Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report.
Am J Kidney Dis 55:2010;1018–1025.
9. Tepel M., van der Giet M., Schwarzfeld C., Laufer U., Liermann D., Zidek W.. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.
N Engl J Med 343:2000;180–184.
10. Weisbord S.D., Mor M.K., Resnick A.L., Hartwig K.C., Palevsky P.M., Fine M.J.. Incidence and outcomes of contrast-induced AKI following computed tomography.
Clin J Am Soc Nephrol 3:2008;1274–1281.
11. Guevara M., Fernandez-Esparrach G., Alessandria C., Torre A., Terra C., Montana X., Piera C., Alvarez M.L., Jimenez W., Gines P., Arroyo V.. Effects of contrast media on renal function in patients with cirrhosis: a prospective study.
Hepatology 40:2004;646–651.
12. Najjar M., Hamad A., Salameh M., Agarwal A., Feinfeld D.A.. The risk of radiocontrast nephropathy in patients with cirrhosis.
Ren Fail 24:2002;11–18.
13. Lodhia N., Kader M., Mayes T., Mantry P., Maliakkal B.. Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis.
World J Gastroenterol 15:2009;1459–1464.
14. Hampel H., Bynum G.D., Zamora E., El-Serag H.B.. Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis.
Am J Gastroenterol 96:2001;2206–2210.
15. Prakash J., Mahapatra A.K., Ghosh B., Arora P., Jain A.K.. Clinical spectrum of renal disorders in patients with cirrhosis of liver.
Ren Fail 33:2011;40–46.
16. Farrugia A.. Albumin usage in clinical medicine: tradition or therapeutic?
Transfus Med Rev 24:2010;53–63.
17. Nicholson J.P., Wolmarans M.R., Park G.R.. The role of albumin in critical illness.
Br J Anaesth 85:2000;599–610.
18. Bunn F., Trivedi D., Ashraf S.. Colloid solutions for fluid resuscitation.
Cochrane Database Syst Rev CD001319:2008.
19. Wilkes M.M., Navickis R.J.. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials.
Ann Intern Med 135:2001;149–164.
20. Runyon B.A.. Management of adult patients with ascites due to cirrhosis: an update.
Hepatology 49:2009;2087–2107.
21. Russo D., Minutolo R., Cianciaruso B., Memoli B., Conte G., De Nicola L.. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure.
J Am Soc Nephrol 6:1995;1451–1458.
22. Tumlin J.A., Wang A., Murray P.T., Mathur V.S.. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy.
Am Heart J 143:2002;894–903.
23. Heinrich M.C., Kuhlmann M.K., Grgic A., Heckmann M., Kramann B., Uder M.. Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro.
Radiology 235:2005;843–849.
24. Persson P.B., Hansell P., Liss P.. Pathophysiology of contrast medium-induced nephropathy.
Kidney Int 68:2005;14–22.
25. Lamke L.O., Liljedahl S.O.. Plasma volume expansion after infusion of 5%, 20% and 25% albumin solutions in patients.
Resuscitation 5:1976;85–92.
26. Holt M.E., Ryall M.E., Campbell A.K.. Albumin inhibits human polymorphonuclear leucocyte luminol-dependent chemiluminescence: evidence for oxygen radical scavenging.
Br J Exp Pathol 65:1984;231–241.
27. Chen T.A., Tsao Y.C., Chen A., Lo G.H., Lin C.K., Yu H.C., Cheng L.C., Hsu P.I., Tsai W.L.. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis.
Scand J Gastroenterol 44:2009;619–625.
28. Quinlan G.J., Mumby S., Martin G.S., Bernard G.R., Gutteridge J.M., Evans T.W.. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury.
Crit Care Med 32:2004;755–759.
29. Cholongitas E., Shusang V., Marelli L., Nair D., Thomas M., Patch D., Burns A., Sweny P., Burroughs A.K.. Review article: renal function assessment in cirrhosis—difficulties and alternative measurements.
Aliment Pharmacol Ther 26:2007;969–978.